Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions (OBBYSS)

March 15, 2018 updated by: PD Dr. Grégoire Wuerzner, Centre Hospitalier Universitaire Vaudois

Effect of Weight Loss Induced by a Bypass Surgery on Renal Salt Excretion, Renal Hemodynamic and on Neurohormonal Responses During an Induced Orthostatic Stress in Obese Patients

The sympathetic nervous (SNS) and the renin angiotensin aldosterone system (RAS) have a direct impact on renal hemodynamic, hormonal secretion and vasoactive peptide. Many mechanisms including the SNS, RAS and renal sodium handling could explain the pathogenesis of hypertension in obese patients. Lifestyle changes and bariatric surgery induce weight loss, which is associated with blood pressure lowering in obese patients. A diminution in the renal sympathetic stimulation and RAS activation could explain this effect.

The AIM of this study is to show that weight loss induced by bypass surgery in obese patients affects renal salt excretion under " low body negative pressure (LBNP)" conditions .

Secondary objectives are to investigate the impact of weight loss on renal hemodynamic (glomerular filtration rate (GFR), renal plasma flow) and neurohormonal responses under " low body negative pressure conditions ". We will also analyse renal blood oxygenation with Blood Oxygenation dependant IRM (BOLD-IRM) technique before and after weight loss.

The population of this study will consist in two groups including 36 patients. The first one will include 24 obese patients that are going to undergo a bariatric surgery. The second one will include 12 obese patients without any weight loss associated surgery.

Both group will undergo 3 investigation days. Each patient will have to undergo a screening visit that will provide dietary advice to ensure a standardized salt intake (120-180 mmol/day) for the duration of the study. The first investigation will define baseline, the second and third day of investigation will take place after 3 month and 12 month after bariatric surgery for surgical patients or after baseline for patients without surgery. One to two weeks before phase 1 and 3 patients will perform a BOLD-MRI. The surgery group will undergo bariatric surgery between the first investigation phase (baseline) and the second. An ambulatory blood pressure and 24-hour urine collection will precede each investigation day. An investigation day consists in renal hemodynamics, neurohormonal and natriuretic response measurements before, during and after 60 min of LBNP at -30mbar . The duration of the study per subject is going to take 12 months.

Study Overview

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vaud
      • Lausanne, Vaud, Switzerland, 1004
        • Centre Hospitalier Universitaire Vaudois

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patient will briefly be informed about the study during their follow-up at the obesity consultation (Medical Universitary Polyclinic) and the they will be recruited at the Nephrology center in CHUV (Lausanne).

Description

Inclusion Criteria:

  • BMI >35 Kg/m2
  • Understanding and signing the informed consent
  • Estimated glomerular filtration rate >60 ml/min/1.73 m2

Exclusion Criteria:

  • Acute disease
  • Asthma or history of asthma
  • Patient participating in another clinical trial 30 days before the beginning of the study
  • Blood donation (450ml) 2 months before the beginning of the study
  • Chronic medication which influence renal function (NSAIDS, Others)
  • Allergy
  • Documented renal arterial stenosis
  • History of symptomatic orthostatic hypotension
  • Kidney transplantation
  • Kidney malformation / polycystic kidney disease
  • Impaired judgement
  • Liver failure with ascitis
  • Hip circumference at the upper anterior iliac spine > 130cm
  • Waist circumference >180cm and weighing > 220kg
  • Contraindication/Allergy to furosemide, PAH or Inulin
  • Contraindication to MRI if the patient is going to undergo BOLD-MRI
  • Postprandial glycemia > 11.0 mmol/L in diabetic patients
  • Blood pressure > 180/110 assessed by 24 hour blood pressure measurement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
OB - Bariatric surgery (gastric bypass)
Obese patients who will undergo a bariatric surgery (gastric bypass)
OB- Control group
Obese patients who will not undergo surgery - Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in sodium excretion
Time Frame: up to one year
Change in sodium excretion during LBNP conditions
up to one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure, renal hemodynamic and neurohormonal response
Time Frame: up to one year
  • 24 hour blood pressure measurement
  • Inulin clearance for GFR measurement
  • Renal plasma flow measured with p-aminohippuric acid (PAH) administration
  • Renin plasmatic activity
  • Aldosterone (plasma)
  • Leptin (plasma)
  • Adiponectin (plasma)
  • Plasmatic and urinary electrolytes
  • Plasmatic and urinary lithium
up to one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

July 31, 2017

Study Completion (Actual)

July 31, 2017

Study Registration Dates

First Submitted

August 14, 2014

First Submitted That Met QC Criteria

August 14, 2014

First Posted (Estimate)

August 15, 2014

Study Record Updates

Last Update Posted (Actual)

March 16, 2018

Last Update Submitted That Met QC Criteria

March 15, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SNF_ 32003B_149903

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on bariatric surgery (gastric bypass)

Subscribe